CJC-1295 NO DAC (Mod GRF 1-29) 

CJC-1295 NO DAC (Mod GRF 1-29)  is a highly purified synthetic Growth Hormone-Releasing Hormone (GHRH) analog engineered for advanced scientific research involving endocrine physiology, peptide pharmacology, and receptor-mediated cellular signaling. Also known as Modified GRF 1-29 (Mod GRF 1-29), this peptide incorporates targeted amino acid substitutions that improve stability against enzymatic degradation while maintaining high affinity for the Growth Hormone-Releasing Hormone Receptor (GHRHR). Unlike CJC-1295 DAC, this version does not contain a Drug Affinity Complex, allowing researchers to investigate short-duration receptor activation and pulsatile hormone signaling under controlled laboratory conditions.

Researchers utilize CJC-1295 NO DAC (Mod GRF 1-29) to investigate the molecular mechanisms governing Growth Hormone (GH) secretion and downstream Insulin-Like Growth Factor-1 (IGF-1) signaling. Experimental studies continue to explore its effects on endocrine regulation, intracellular communication, metabolic pathways, protein synthesis, cellular growth, and peptide-receptor interactions. Its predictable pharmacokinetic profile makes it particularly valuable for studies requiring transient GHRH receptor stimulation and precise evaluation of hormone-mediated biological responses.

The well-defined molecular structure of CJC-1295 NO DAC (Mod GRF 1-29)  has established it as an important research compound in endocrinology, molecular biology, biotechnology, and peptide science. Academic institutions, biotechnology organizations, and pharmaceutical research laboratories employ this peptide to investigate neuroendocrine signaling, receptor pharmacology, metabolic regulation, and the physiological mechanisms involved in growth hormone release.

Manufacturers produce CJC-1295 NO DAC (Mod GRF 1-29)  as a high-purity, research-grade lyophilized peptide using strict GMP-inspired manufacturing standards and comprehensive analytical quality control. Every production batch undergoes rigorous testing to verify identity, purity, potency, and batch-to-batch consistency, providing researchers with a dependable product for reproducible scientific investigations.

Product Information

• Product Name: CJC-1295 NO DAC (Mod GRF 1-29)
• Strength: 5mg per vial
• Alternative Name: Modified GRF 1-29 (Mod GRF 1-29)
• Peptide Class: Synthetic Growth Hormone-Releasing Hormone (GHRH) analog
• DAC Status: No Drug Affinity Complex (NO DAC)
• Appearance: White to off-white lyophilized powder
• Grade: Research grade
• Purity: High purity (Certificate of Analysis available for applicable batches)
• Intended Use: Laboratory research only

Research Applications

Researchers commonly investigate CJC-1295 NO DAC (Mod GRF 1-29) (5mg) in studies involving:

• Growth Hormone-Releasing Hormone (GHRH) receptor signaling
• Growth Hormone (GH) secretion
• Insulin-Like Growth Factor-1 (IGF-1) pathways
• Endocrine and neuroendocrine biology
• Peptide-receptor pharmacology
• Cellular signaling and molecular biology
• Metabolic regulation research
• Biotechnology and pharmaceutical research

Quality Assurance

Every batch of CJC-1295 NO DAC undergoes comprehensive analytical testing to verify identity, purity, potency, and consistency before release. Strict quality assurance protocols support dependable laboratory performance and reproducible scientific results for academic, biotechnology, and pharmaceutical research.

Storage

Store the lyophilized peptide in a cool, dry laboratory environment protected from moisture, heat, and direct light. After reconstitution, follow validated laboratory storage procedures to preserve peptide stability and maintain sample integrity.

Disclaimer

CJC-1295 NO DAC (Mod GRF 1-29) (5mg) is supplied exclusively for laboratory and scientific research purposes. This product is not intended for human consumption, clinical use, veterinary applications, therapeutic treatment, or diagnostic procedures. Qualified laboratory personnel should handle this research peptide in accordance with established laboratory practices and all applicable regulations.